Mon-Fri 8-16 (GMT +2)
Stereotactic body radiation therapy (SBRT) is well suited for the palliative treatment of metastases in the brain, liver, lungs and sometimes also in the bones.
Hypofractionated stereotactic radiotherapy effectively destroys local metastases. Radiotherapy is often given for metastases after chemotherapy to stabilise the disease. In this way, the disease can be controlled without further chemotherapy.
Oncologists in Finland have long been using hypofractionated stereotactic radiotherapy with great success. In the treatment of metastases, the patient may be given 1 to 5 hypofractionated high-dose radiotherapy doses depending on the size, location and previous treatment of the metastases.
SBRT is used for the treatment of urological and gynaecological cancers, lung, intestinal, liver and breast cancer, and for the treatment of metastases of other cancers. In certain cases, SBRT can also be used as primary treatment for cancer.
Many cancer patients have several concerns when it comes to the coronavirus epidemic, e.g. how does the situation impact my...Read more
In addition to oncology, Jorma Sormunen has years of experience in occupational healthcare. He has personally witnessed how important work...Read more
There are as many reasons to choose a private cancer hospital as there are people. We compiled the reasons most...Read more
The coronavirus is a concern among cancer patients. We listed the most common concerns and the answers to them.Read more